SciClone Pharmaceuticals, Inc. SCLN
11.15 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
11.15 Day range 11.20
8.55 52-week range 11.43
Analyst view
Consensus: hold
Hold
Price target (mean) 14.00
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.22 | 0.22 – 0.22 | -0.08 | +375.0% | 43.87M | 0.0% | 1 |
| Next quarter | 0.21 | 0.21 – 0.21 | 0.12 | +75.0% | 44.29M | +0.5% | 1 |
| Current year | 0.94 | 0.94 – 0.94 | 0.58 | +62.1% | 173.72M | +8.5% | 1 |
| Next year | 1.07 | 1.07 – 1.07 | 0.94 | +13.8% | 185.57M | +6.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 28, 2016 | Maxim Group | Initiated | — | Buy |
| Jun 28, 2015 | MLV & Co. | Initiated | — | Buy |
| Nov 13, 2014 | BWS Financial | Downgrade | — | Hold |
| Jul 15, 2013 | Aegis Capital | Upgrade | — | Buy |
| Feb 24, 2013 | Aegis Capital | Downgrade | — | Hold |
| Sep 17, 2012 | BWS Financial | Upgrade | — | Buy |